世界の経口固形剤形製剤市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Oral Solid Dosage Pharmaceutical Formulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15047 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、経口固形剤形製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口固形剤形製剤の種類別市場規模（即時リリース、拡張リリース、その他）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経口固形剤形製剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Gilead、Merck、Novartis、Pfizer、AbbVie、Boehringer Ingelheim ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：即時リリース、拡張リリース、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、ドラッグストア、その他 ・経口固形剤形製剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口固形剤形製剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口固形剤形製剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口固形剤形製剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口固形剤形製剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Oral Solid Dosage Pharmaceutical Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral Solid Dosage Pharmaceutical Formulation size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oral Solid Dosage Pharmaceutical Formulation market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Oral Solid Dosage Pharmaceutical Formulation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immediate Release
Extended Release
Others

Market segment by Application, can be divided into
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others

Market segment by players, this report covers
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oral Solid Dosage Pharmaceutical Formulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oral Solid Dosage Pharmaceutical Formulation, with revenue, gross margin and global market share of Oral Solid Dosage Pharmaceutical Formulation from 2019 to 2021.
Chapter 3, the Oral Solid Dosage Pharmaceutical Formulation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oral Solid Dosage Pharmaceutical Formulation market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Oral Solid Dosage Pharmaceutical Formulation research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation by Type
1.2.1 Overview: Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type in 2020
1.2.3 Immediate Release
1.2.4 Extended Release
1.2.5 Others
1.3 Global Oral Solid Dosage Pharmaceutical Formulation Market by Application
1.3.1 Overview: Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Stores
1.3.5 Others
1.4 Global Oral Solid Dosage Pharmaceutical Formulation Market Size & Forecast
1.5 Global Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast by Region
1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region, (2016-2021)
1.5.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size and Prospect (2016-2026)
1.5.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size and Prospect (2016-2026)
1.5.6 South America Oral Solid Dosage Pharmaceutical Formulation Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Solid Dosage Pharmaceutical Formulation Market Drivers
1.6.2 Oral Solid Dosage Pharmaceutical Formulation Market Restraints
1.6.3 Oral Solid Dosage Pharmaceutical Formulation Trends Analysis
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.1.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.2.4 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.3.4 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 Gilead
2.4.1 Gilead Details
2.4.2 Gilead Major Business
2.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.4.4 Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Gilead Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.5.4 Merck Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.6.4 Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.7.4 Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.8.4 AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
2.9.4 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oral Solid Dosage Pharmaceutical Formulation Players Market Share
3.2.2 Top 10 Oral Solid Dosage Pharmaceutical Formulation Players Market Share
3.2.3 Market Competition Trend
3.3 Oral Solid Dosage Pharmaceutical Formulation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2016-2021)
4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2016-2021)
5.2 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2026)
6.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2026)
6.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
6.3.1 North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2026)
6.3.2 United States Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
6.3.3 Canada Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
6.3.4 Mexico Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2026)
7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2026)
7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
7.3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2026)
7.3.2 Germany Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
7.3.3 France Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
7.3.5 Russia Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
7.3.6 Italy Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2026)
8.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2026)
8.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region
8.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Region (2016-2026)
8.3.2 China Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
8.3.3 Japan Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
8.3.4 South Korea Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
8.3.5 India Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
8.3.7 Australia Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2026)
9.2 South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2026)
9.3 South America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
9.3.1 South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2026)
9.3.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
9.3.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2026)
10.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2026)
10.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
10.3.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2026)
10.3.2 Turkey Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
10.3.4 UAE Oral Solid Dosage Pharmaceutical Formulation Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 9. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 11. Bristol-Myers Squibb Major Business
Table 12. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 13. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly Major Business
Table 16. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 17. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Gilead Corporate Information, Head Office, and Major Competitors
Table 19. Gilead Major Business
Table 20. Gilead Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 21. Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merck Corporate Information, Head Office, and Major Competitors
Table 23. Merck Major Business
Table 24. Merck Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 25. Merck Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 29. Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 33. Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AbbVie Corporate Information, Head Office, and Major Competitors
Table 35. AbbVie Major Business
Table 36. AbbVie Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 37. AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 39. Boehringer Ingelheim Major Business
Table 40. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product and Solutions
Table 41. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) by Players (2019-2021)
Table 43. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players (2019-2021)
Table 44. Breakdown of Oral Solid Dosage Pharmaceutical Formulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Oral Solid Dosage Pharmaceutical Formulation Players Head Office, Products and Services Provided
Table 46. Oral Solid Dosage Pharmaceutical Formulation Mergers & Acquisitions in the Past Five Years
Table 47. Oral Solid Dosage Pharmaceutical Formulation New Entrants and Expansion Plans
Table 48. Global Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) by Type (2016-2021)
Table 49. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2016-2021)
Table 50. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Type (2021-2026)
Table 51. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2021)
Table 52. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Application (2021-2026)
Table 53. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oral Solid Dosage Pharmaceutical Formulation Picture
Figure 2. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type in 2020
Figure 3. Immediate Release
Figure 4. Extended Release
Figure 5. Others
Figure 6. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application in 2020
Figure 7. Hospital Pharmacy Picture
Figure 8. Retail Pharmacy Picture
Figure 9. Drug Stores Picture
Figure 10. Others Picture
Figure 11. Global Oral Solid Dosage Pharmaceutical Formulation Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region (2016-2026)
Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region in 2020
Figure 15. North America Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Oral Solid Dosage Pharmaceutical Formulation Market Drivers
Figure 21. Oral Solid Dosage Pharmaceutical Formulation Market Restraints
Figure 22. Oral Solid Dosage Pharmaceutical Formulation Market Trends
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 25. Eli Lilly Recent Developments and Future Plans
Figure 26. Gilead Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. AbbVie Recent Developments and Future Plans
Figure 31. Boehringer Ingelheim Recent Developments and Future Plans
Figure 32. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players in 2020
Figure 33. Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in 2020
Figure 35. Global Top 10 Players Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type in 2020
Figure 38. Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Type (2021-2026)
Figure 39. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Application in 2020
Figure 40. Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Application (2021-2026)
Figure 41. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2016-2026)
Figure 42. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2016-2026)
Figure 43. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2016-2026)
Figure 44. United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2016-2026)
Figure 48. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2016-2026)
Figure 49. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2016-2026)
Figure 50. Germany Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region (2016-2026)
Figure 58. China Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2016-2026)
Figure 65. South America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2016-2026)
Figure 66. South America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---